Myrlene Sanon, MPH

Johnson & Johnson

Poster(s):

• P3244 - Symptom and Quality of Life Benefits of Achieving Deep Remission – A Real-World Survey of Patients With Crohn’s Disease
  Monday, October 27, 2025

  10:30 AM - 4:00 PM PDT

• P3245 - Longer Sustained Remission in Crohn’s Disease With Guselkumab versus Ustekinumab Treatment: Projections From a Disease Model
  Monday, October 27, 2025

  10:30 AM - 4:00 PM PDT

• P3246 - Induction Efficacy of Subcutaneous Guselkumab vs Advanced Therapies in Moderately-to-Severely Active Crohn’s Disease: A Bayesian Network Meta-Analysis
  Monday, October 27, 2025

  10:30 AM - 4:00 PM PDT

• P3247 - Symptom and Quality of Life Benefits of Achieving Deep Remission – A Real-World Survey of Patients With Ulcerative Colitis
  Monday, October 27, 2025

  10:30 AM - 4:00 PM PDT